OBJECTIVES: To determine whether odor identification ability is associated with the 5-year incidence of cognitive impairment in a large population of older adults with normal cognition at baseline and whether olfactory impairment contributes to the prediction of cognitive decline. DESIGN: Population-based longitudinal study. SETTING: Beaver Dam, Wisconsin. PARTICIPANTS: One thousand nine hundred twenty participants in the Epidemiology of Hearing Loss Study (mean age 66.9). MEASUREMENTS: Olfaction was measured using the San Diego Odor Identification Test (SDOIT). Incident cognitive impairment was defined as a Mini-Mental State Examination (MMSE) score of less than 24 or reported diagnosis of dementia or Alzheimer's disease (AD) at follow-up in participants with a MMSE score of 24 or greater and no diagnosis of dementia or AD at baseline. RESULTS: There was a significant association between olfactory impairment at baseline and 5-year incidence of cognitive impairment (odds ratio (OR)=6.62, 95% confidence interval (CI)=4.36-10.05). The association remained significant after adjusting for possible confounders (OR=3.72, 95% CI=2.31-5.99). The positive predictive value of the SDOIT was 15.9%, the negative predictive value was 97.2%, the sensitivity was 55.1%, and the specificity was 84.4% for 5-year incidence of cognitive impairment. CONCLUSION: Olfactory impairment at baseline was strongly associated with 5-year incidence of cognitive impairment as measured using the MMSE. Odor identification testing may be useful in high-risk settings, but not in the general population, to identify patients at risk for cognitive decline.
OBJECTIVES: To determine whether odor identification ability is associated with the 5-year incidence of cognitive impairment in a large population of older adults with normal cognition at baseline and whether olfactory impairment contributes to the prediction of cognitive decline. DESIGN: Population-based longitudinal study. SETTING: Beaver Dam, Wisconsin. PARTICIPANTS: One thousand nine hundred twenty participants in the Epidemiology of Hearing Loss Study (mean age 66.9). MEASUREMENTS: Olfaction was measured using the San Diego Odor Identification Test (SDOIT). Incident cognitive impairment was defined as a Mini-Mental State Examination (MMSE) score of less than 24 or reported diagnosis of dementia or Alzheimer's disease (AD) at follow-up in participants with a MMSE score of 24 or greater and no diagnosis of dementia or AD at baseline. RESULTS: There was a significant association between olfactory impairment at baseline and 5-year incidence of cognitive impairment (odds ratio (OR)=6.62, 95% confidence interval (CI)=4.36-10.05). The association remained significant after adjusting for possible confounders (OR=3.72, 95% CI=2.31-5.99). The positive predictive value of the SDOIT was 15.9%, the negative predictive value was 97.2%, the sensitivity was 55.1%, and the specificity was 84.4% for 5-year incidence of cognitive impairment. CONCLUSION: Olfactory impairment at baseline was strongly associated with 5-year incidence of cognitive impairment as measured using the MMSE. Odor identification testing may be useful in high-risk settings, but not in the general population, to identify patients at risk for cognitive decline.
Authors: A B Graves; J D Bowen; L Rajaram; W C McCormick; S M McCurry; G D Schellenberg; E B Larson Journal: Neurology Date: 1999-10-22 Impact factor: 9.910
Authors: K J Cruickshanks; T L Wiley; T S Tweed; B E Klein; R Klein; J A Mares-Perlman; D M Nondahl Journal: Am J Epidemiol Date: 1998-11-01 Impact factor: 4.897
Authors: Robert S Wilson; Julie A Schneider; Steven E Arnold; Yuxiao Tang; Patricia A Boyle; David A Bennett Journal: Arch Gen Psychiatry Date: 2007-07
Authors: Carla R Schubert; Mary E Fischer; A Alex Pinto; Yanjun Chen; Barbara E K Klein; Ronald Klein; Michael Y Tsai; Ted S Tweed; Karen J Cruickshanks Journal: J Am Geriatr Soc Date: 2019-04-01 Impact factor: 5.562
Authors: Elizabeth M Krantz; C R Schubert; D S Dalton; W Zhong; G H Huang; B E K Klein; R Klein; F J Nieto; K J Cruickshanks Journal: Chem Senses Date: 2009-04-10 Impact factor: 3.160
Authors: Dara R Adams; Gaurav S Ajmani; Vivian C Pun; Kristen E Wroblewski; David W Kern; L Philip Schumm; Martha K McClintock; Helen H Suh; Jayant M Pinto Journal: Int Forum Allergy Rhinol Date: 2016-09-13 Impact factor: 3.858
Authors: Mary E Fischer; Karen J Cruickshanks; David M Nondahl; Barbara E K Klein; Ronald Klein; James S Pankow; Ted S Tweed; Dayna S Dalton; Adam J Paulsen Journal: Ear Hear Date: 2017 May/Jun Impact factor: 3.570